Patents by Inventor Vivian Georgousis

Vivian Georgousis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID FORMULATIONS
    Publication number: 20160030572
    Abstract: Disclosed is a concentrate for dilution comprising a S1P receptor agonist or a pharmaceutically acceptable salt thereof, propylene glycol and optionally glycerin. This formulation is adapted for patients in a difficult condition to swallow.
    Type: Application
    Filed: October 15, 2015
    Publication date: February 4, 2016
    Applicant: NOVARTIS AG
    Inventors: Vivian GEORGOUSIS, Wei-Qin Tong
  • LIQUID FORMULATIONS
    Publication number: 20150080347
    Abstract: Disclosed is a concentrate for dilution comprising a S1P receptor agonist or a pharmaceutically acceptable salt thereof, propylene glycol and optionally glycerin. This formulation is adapted for patients in a difficult condition to swallow.
    Type: Application
    Filed: December 6, 2013
    Publication date: March 19, 2015
    Applicant: NOVARTIS AG
    Inventors: Vivian Georgousis, Wei-Qin Tong
  • LIQUID FORMULATIONS
    Publication number: 20140179636
    Abstract: Disclosed is a concentrate for dilution comprising a S1P receptor agonist or a pharmaceutically acceptable salt thereof, propylene glycol and optionally glycerin. This formulation is adapted for patients in a difficult condition to swallow.
    Type: Application
    Filed: December 6, 2013
    Publication date: June 26, 2014
    Applicant: NOVARTIS AG
    Inventors: Vivian Georgousis, Wei-Qin Tong
  • LIQUID FORMULATIONS
    Publication number: 20120328664
    Abstract: Disclosed is a concentrate for dilution comprising a S1P receptor agonist or a pharmaceutically acceptable salt thereof, propylene glycol and optionally glycerin. This formulation is adapted for patients in a difficult condition to swallow.
    Type: Application
    Filed: September 7, 2012
    Publication date: December 27, 2012
    Inventors: Vivian Georgousis, Wei-Qin Tong
  • Liquid Formulations
    Publication number: 20080194526
    Abstract: Disclosed is a concentrate for dilution comprising a S1P receptor agonist or a pharmaceutically acceptable salt thereof, propylene glycol and optionally glycerin. This formulation is adapted for patients in a difficult condition to swallow.
    Type: Application
    Filed: August 8, 2006
    Publication date: August 14, 2008
    Inventors: Vivian Georgousis, Wei-Qin Tong
  • Pharmaceutical composition comprising 5-methyl-2(2'-chloro-6'-fluoroanilino)phenylacetic acid
    Publication number: 20070123593
    Abstract: The invention relates to a composition for the treatment of a cyclooxygenase-2-mediated disorder or condition comprising 5-methyl-2-(2?-chloro-6?-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt, preferably the potassium salt, thereof suitable for parenteral administration, and to a method for the treatment of a cyclooxygenase-2-mediated disorder or condition in a human or animal in need of such treatment by parenteral administration of 5-methyl-2-(2?-chloro-6?-fluroanilino)phenylacetic acid or a pharmaceutically acceptable salt, preferably the potassium salt, thereof.
    Type: Application
    Filed: October 7, 2004
    Publication date: May 31, 2007
    Inventors: Rose-Marie Dannenfelser, Vivian Georgousis, Maha Khaled, Tarun Patel, Joseph Sikora, Barbara Wang